Spyre Therapeutics, Inc.

SYRENasdaqCIK: 0001636282

Spyre Therapeutics, Inc. (SYRE) shows 34 recent insider filings from 10 insiders, with all of them on the sell side. With $0 in purchases and $426.4M in sales, the recent tape is heavily weighted toward selling (net sales of $426.4M). Fairmount Funds Management LLC (Director) is the most active by dollar volume, and the single largest transaction was $399.7M by Fairmount Funds Management LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume

$466.0M

Purchases

Sales

$426.4M

Unique Insiders

Price & Insider Trades

SYRE daily price over the past year with every insider buy and sale overlaid.

Price data is delayed and provided for context only — not investment advice.

Recent Insider Trades

34 loaded


Jul 2	SYRE Spyre Therapeutics, Inc.	Sloan Sheldon	Chief Medical Officer	Sell	$730.9K
Jul 2	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$1.3M
Jul 2	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$658.0K
Jun 26	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$1.3M
Jun 23	SYRE Spyre Therapeutics, Inc.	Fairmount Funds Management LLC	Director	Sell	$399.7M
Jun 23	SYRE Spyre Therapeutics, Inc.	HENDERSON MICHAEL THOMAS	Director	Sell	$2.0M
Jun 3	SYRE Spyre Therapeutics, Inc.	Sloan Sheldon	Chief Medical Officer	Sell	$625.0K
Jun 3	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$532.9K
Jun 3	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$1.1M
May 29	SYRE Spyre Therapeutics, Inc.	Milligan Sandra	Director	Award	$582.0K
May 29	SYRE Spyre Therapeutics, Inc.	HENDERSON MICHAEL THOMAS	Director	Award	$582.0K
May 29	SYRE Spyre Therapeutics, Inc.	McKenna Mark C.	Director	Award	$582.0K
May 29	SYRE Spyre Therapeutics, Inc.	Stelzer Laurie	Director	Award	$582.0K
May 29	SYRE Spyre Therapeutics, Inc.	Albers Jeffrey W.	Director	Award	$582.0K
May 29	SYRE Spyre Therapeutics, Inc.	Fairmount Funds Management LLC	Director	Award	$582.0K
May 8	SYRE Spyre Therapeutics, Inc.	HENDERSON MICHAEL THOMAS	Director	Sell	$6.0M
May 1	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$1.1M
May 1	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$892.1K
May 1	SYRE Spyre Therapeutics, Inc.	Sloan Sheldon	Chief Medical Officer	Sell	$5.6M
Apr 3	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$739.9K
Apr 3	SYRE Spyre Therapeutics, Inc.	Sloan Sheldon	Chief Medical Officer	Sell	$397.9K
Apr 3	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$370.1K
Mar 3	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$101.6K
Mar 3	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$632.9K
Feb 4	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$492.0K
Jan 23	SYRE Spyre Therapeutics, Inc.	HENDERSON MICHAEL THOMAS	Director	Other	$0
Jan 13	SYRE Spyre Therapeutics, Inc.	Sloan Sheldon	Chief Medical Officer	Award	$4.3M
Jan 13	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Award	$4.3M
Jan 13	SYRE Spyre Therapeutics, Inc.	King-Jones Heidy	See Remarks	Award	$4.3M
Jan 13	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Award	$16.2M
Jan 6	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$460.1K
Dec 3	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$435.4K
Nov 5	SYRE Spyre Therapeutics, Inc.	Turtle Cameron	Chief Executive Officer, Director	Sell	$1.0M
Sep 3	SYRE Spyre Therapeutics, Inc.	Burrows Scott L	Chief Financial Officer	Sell	$299.6K

34 filings